Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXR0UR
|
||||
Drug Name |
(S)-N-[(R)-1-Formyl-2-(1H-indol-3-yl)-ethyl]-3-(naphthalene-1-sulfonylamino)-succinamic acid methyl ester
|
||||
Synonyms |
CHEMBL132595
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H25N3O6S
|
||||
Canonical SMILES |
COC(=O)C[C@H](NS(=O)(=O)c1cccc2ccccc12)C(=O)N[C@H](Cc3c[nH]c4ccccc34)C=O
|
||||
InChI |
InChI=1S/C26H25N3O6S/c1-35-25(31)14-23(29-36(33,34)24-12-6-8-17-7-2-3-10-21(17)24)26(32)28-19(16-30)13-18-15-27-22-11-5-4-9-20(18)22/h2-12,15-16,19,23,27,29H,13-14H2,1H3,(H,28,32)/t19-,23+/m1/s1
|
||||
InChIKey |
VQKHIDNPFSGTTG-XXBNENTESA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.